Search Within

Matthew J Matasar

Refine Results
Formats
  1. Meeting Abstract (75)
  2. Journal Article (40)
  3. Book Section (3)
  4. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (119)
  2. Hematologic Oncology, Division of (119)
  3. Lymphoma (119)
  4. Lymphoma Service (119)
  5. Population Sciences Research Program (119)
  6. Survivorship Research (119)

More Groups

People
  1. Craig Moskowitz (69)
  2. Andrew Zelenetz (52)
  3. David Straus (46)
  4. Paul Hamlin (45)
  5. Alison Moskowitz (44)
  6. Steven Horwitz (42)

More People

Years
  1. 2018 (14)
  2. 2017 (27)
  3. 2016 (17)
  4. 2015 (22)
  5. 2014 (12)
  6. 2013 (8)

More Years

Publications
  1. Blood (49)
  2. Journal of Clinical Oncology (14)
  3. Biology of Blood and Marrow Transplantation (10)
  4. Hematological Oncology (9)
  5. Annals of Oncology (3)
  6. British Journal of Haematology (3)

More Publications

Publishers
  1. American Society of Hematology (50)
  2. Elsevier Inc. (15)
  3. American Society of Clinical Oncology (14)
  4. Wiley Blackwell (11)
  5. Oxford University Press (7)
  6. John Wiley & Sons (3)

More Publishers

Results (119)

Export to EndNote | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD30 is a potential therapeutic target in patients with HTLV-1 associated adult T-cell leukemia/lymphoma presenting outside of Japan
    Meeting Abstract

    Lunning, M. A.; Chiu, A.; Feldstein, J. T.; Maragulia, J. C.; Moskowitz, A.; Matasar, M. J.; Straus, D. J.; Noy, A.; Myskowski, P. L.; Zelenetz, A. D.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Histiocytic sarcoma of the central nervous system: A case report
    Meeting Abstract

    Curry, R.; Joyce, J.; Rosenblum, M.; Jaffe, E.; Matasar, M.; Lin, O.; Fisher, R.; Omuro, A.
    Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma
    Journal Article

    Moskowitz, C. H.; Matasar, M. J.; Zelenetz, A. D.; Nimer, S. D.; Gerecitano, J.; Hamlin, P.; Horwitz, S.; Moskowitz, A. J.; Noy, A.; Palomba, L.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Risk of nausea and vomiting in patients with lymphoma undergoing high dose therapy with autologous stem cell rescue
    Meeting Abstract

    Puto, M.; Adel, N.; Riedel, E.; Giralt, S. A.; Matasar, M. J.
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • Expert second-opinion pathology review of lymphoma in the era of the World Health Organization classification
    Journal Article

    Matasar, M. J.; Shi, W.; Silberstein, J.; Lin, O.; Busam, K. J.; Teruya-Feldstein, J.; Filippa, D. A.; Zelenetz, A. D.; Noy, A.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Peripheral T-cell lymphomas
    Book Section

    Horwitz, S. M.; Matasar, M. J.
    In O'Brien, S. M.; Vose, J. M.; Kantarjian, H. M. (Eds.) Management of Hematologic Malignancies (2011)

    Fulltext@MSK | Save
  • A phase II study of ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory aggressive B-cell lymphoma prior to autologous stem cell transplantation (ASCT)
    Meeting Abstract

    Matasar, M. J.; Czuczman, M. S.; Rodriguez, M. A.; Fennessy, M.; Shea, T. C.; Spitzer, G.; Lossos, I. S.; Kharfan-Dabaja, M. A.; Joyce, R.; Fayad, L.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Risk-adapted therapy using biopsy confirmation of abnormal interim FDG-PET for patients with advanced stage diffuse large B cell lymphoma (DLBCL), and exploratory evaluation of FLT-PET
    Meeting Abstract

    Moskowitz, C. H.; Schoder, H.; Hamlin, P. A.; Gerecitano, J. F.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; Noy, A.; Palomba, M.; Portlock, C. S.; more...
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • Updated results of a phase II trial of bendamustine in relapsed and refractory Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Hamlin, P.; Gerecitano, J.; Horwitz, S.; Matasar, M.; Noy, A.; Palomba, M. L.; Portlock, C.; Straus, D.; Graustein, T.; more...
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • High number of successful mobilizations associated with the use of plerixafor and colony stimulating factors in patients with multiple myeloma (MM) and lymphoma treated at Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Adel, N. G.; Mathew, S.; Harnicar, S. J.; Mccullagh, E.; Landau, H.; Giralt, S.; Vanak, J.; Chimento, D.; Lucarelli, C.; Matasar, M. J.; more...
    Blood (2010)

    Fulltext@MSK | Save